Fuelling cancer treatment through gut health.
This winning Breakthrough Fund researcher uses the microbiome to improve immunotherapy treatment.
By connecting visionary donors and forward-thinking companies focused on cancer, we can close the gap between research and real-world impact — fast-tracking novel therapeutics, cutting-edge diagnostics, revolutionary medical devices and next-generation treatments.
Through venture philanthropy — a model that applies investment principles to charitable giving to help bridge gaps in commercialization — we’re fueling solutions that will lead to earlier diagnoses, better care and improved outcomes for the more than 24,000 Albertans diagnosed each year.
Lindsay Gilbert
Director, Innovation & Partnerships
Lindsay.Gilbert@albertacancer.ca
Cory Janssen
Joanna Shea
Jeff Robson
Jil Macdonald
This winning Breakthrough Fund researcher uses the microbiome to improve immunotherapy treatment.
Local startup Oncobiotix to receive $100,000 to advance cancer and microbiome research May 31, 2024 (Calgary, Alberta) – The Alberta Cancer Foundation is pleased to announce the latest recipient of
Entos Pharmaceuticals and 48Hour Discovery named as first recipients of Breakthrough Fund Edmonton, AB – Jan 23, 2024 – The Alberta Cancer Foundation is thrilled to announce that Entos Pharmaceuticals
We recognize and thank SickKids Foundation for their guidance in developing the Breakthrough Fund.
